Profile
Full Name
Achilles Therapeutics plcTicker Symbol
ACHLExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United KingdomIPO
March 31, 2021Indexes
Not includedWebsite
http://www.achillestx.comEmployees
204Key Details
Price
$1.48
Market cap
$60.83M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.74(+4.40% YoY)
PE ratio
-
Next earnings date
N/ANext ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Achilles Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 5, 24 Piper Sandler
NeutralApr 5, 24 Chardan Capital
BuyDec 14, 23 B of A Securities
UnderperformAug 7, 23 Chardan Capital
BuyMay 11, 23 Chardan Capital
BuyDec 7, 22 Piper Sandler
OverweightDec 7, 22 Chardan Capital
BuyApr 26, 21 Piper Sandler
OverweightApr 26, 21 Oppenheimer
OutperformApr 26, 21 JP Morgan
UnderweightInstitutional Ownership
- What is the ticker symbol for Achilles Therapeutics?
- Does Achilles Therapeutics pay dividends?
- What sector is Achilles Therapeutics in?
- What industry is Achilles Therapeutics in?
- What country is Achilles Therapeutics based in?
- When did Achilles Therapeutics go public?
- Is Achilles Therapeutics in the S&P 500?
- Is Achilles Therapeutics in the NASDAQ 100?
- Is Achilles Therapeutics in the Dow Jones?
- When was Achilles Therapeutics's last earnings report?
- When does Achilles Therapeutics report earnings?
- Should I buy Achilles Therapeutics stock now?
What is the ticker symbol for Achilles Therapeutics?
The ticker symbol for Achilles Therapeutics is NASDAQ:ACHL
Does Achilles Therapeutics pay dividends?
No, Achilles Therapeutics does not pay dividends
What sector is Achilles Therapeutics in?
Achilles Therapeutics is in the Healthcare sector
What industry is Achilles Therapeutics in?
Achilles Therapeutics is in the Biotechnology industry
What country is Achilles Therapeutics based in?
Achilles Therapeutics is headquartered in United Kingdom
When did Achilles Therapeutics go public?
Achilles Therapeutics's initial public offering (IPO) was on March 31, 2021
Is Achilles Therapeutics in the S&P 500?
No, Achilles Therapeutics is not included in the S&P 500 index
Is Achilles Therapeutics in the NASDAQ 100?
No, Achilles Therapeutics is not included in the NASDAQ 100 index
Is Achilles Therapeutics in the Dow Jones?
No, Achilles Therapeutics is not included in the Dow Jones index
When was Achilles Therapeutics's last earnings report?
Achilles Therapeutics's most recent earnings report was on Apr 4, 2025
When does Achilles Therapeutics report earnings?
The date for Achilles Therapeutics's next earnings report has not been announced yet
Should I buy Achilles Therapeutics stock now?
As of today, analysts generally recommend a 'Sell' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions